Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Stenvang

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Scientific Reports|March 8, 2014
Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibodyDavid Hersi Smith, Anne-Marie Kanstrup Fiehn, Louise Fogh, et al.
Plos One|April 24, 2014
Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalabilityErika Assarsson, Martin Lundberg, Göran Holmquist, et al.
Journal of Translational Medicine|October 11, 2013
Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individualsStine Buch Thorsen, Martin Lundberg, Andrea Villablanca, et al.
Nature Genetics|March 23, 2011
Silencing of microRNA families by seed-targeting tiny LNAsSusanna Obad, Camila O dos Santos, Andreas Petri, et al.
Journal of Extracellular Vesicles|September 1, 2016
miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancerMarie Stampe Ostenfeld, Steffen Grann Jensen, Dennis Kjølhede Jeppesen, et al.
International Journal of Molecular Sciences|May 7, 2025
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in CancerAnamarija Pfeiffer, Luca Di Leo, Marc Baker Bechmann, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 19, 2015
Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathwaysStine Ninel Hansen, David Westergaard, Mathilde Borg Houlberg Thomsen, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4Enikö Sonkoly, Peter Janson, Marja-Leena Majuri, et al.
International Journal of Molecular Sciences|July 26, 2020
ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal CancerJesper Andreas Palshof, Camilla Natasha Cederbye, Estrid Vilma Solyom Høgdall, et al.
Investigational New Drugs|April 24, 2025
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancerSusy Shim, Anke Reinacher-Schick, Anna-Lena Kraeft, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Scientific Reports|March 8, 2014
Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibodyDavid Hersi Smith, Anne-Marie Kanstrup Fiehn, Louise Fogh, et al.
Plos One|April 24, 2014
Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalabilityErika Assarsson, Martin Lundberg, Göran Holmquist, et al.
Journal of Translational Medicine|October 11, 2013
Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individualsStine Buch Thorsen, Martin Lundberg, Andrea Villablanca, et al.
Nature Genetics|March 23, 2011
Silencing of microRNA families by seed-targeting tiny LNAsSusanna Obad, Camila O dos Santos, Andreas Petri, et al.
Journal of Extracellular Vesicles|September 1, 2016
miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancerMarie Stampe Ostenfeld, Steffen Grann Jensen, Dennis Kjølhede Jeppesen, et al.
International Journal of Molecular Sciences|May 7, 2025
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in CancerAnamarija Pfeiffer, Luca Di Leo, Marc Baker Bechmann, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 19, 2015
Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathwaysStine Ninel Hansen, David Westergaard, Mathilde Borg Houlberg Thomsen, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4Enikö Sonkoly, Peter Janson, Marja-Leena Majuri, et al.
International Journal of Molecular Sciences|July 26, 2020
ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal CancerJesper Andreas Palshof, Camilla Natasha Cederbye, Estrid Vilma Solyom Høgdall, et al.
Investigational New Drugs|April 24, 2025
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancerSusy Shim, Anke Reinacher-Schick, Anna-Lena Kraeft, et al.
Pageof 8